Key Recent Advances in Atherosclerosis Treatment with Modern Lipid-lowering Drugs: The New Frontier with PCSK9 Inhibitors

Eur Cardiol. 2017 Aug;12(1):30-32. doi: 10.15420/ecr.2017.12.1.GE3.

Authors

Antoni Martínez-Rubio^{1

2}, Román Freixa Pamias^{1

2}

Affiliations

¹ President of the International Society of Cardiovascular Pharmacotherapy, based at the Department of Cardiology, University Hospital of Sabadell and the Autonomous University of Barcelona, Barcelona, Spain.
² Member of the International Society of Cardiovascular Pharmacotherapy, based at the Department of Cardiology, Moisès Broggi Hospital, Barcelona, Spain.

No abstract available

Publication types

Editorial